Last reviewed · How we verify
Drug use: modafinil
At a glance
| Generic name | Drug use: modafinil |
|---|---|
| Sponsor | K. Lieb |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention (PHASE2)
- Modafinil for the Treatment of Alcohol Use Disorders (PHASE2)
- Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke (PHASE2)
- Medications for Stopping Cocaine Dependence and Preventing Relapse (PHASE2)
- A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence (PHASE2)
- Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players (PHASE1)
- A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence (PHASE2)
- Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Drug use: modafinil CI brief — competitive landscape report
- Drug use: modafinil updates RSS · CI watch RSS
- K. Lieb portfolio CI